SPM 962
SPM 962 is a pharmaceutical drug with 12 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 12 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
7
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
12 of 12 finished
0.0%
0 ended early
0
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage, Idiopathic Parkinson's Disease
Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa
Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)
A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients
A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients
Clinical Trials (12)
A Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage, Idiopathic Parkinson's Disease
Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa
Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)
A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients
A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients
A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome
A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease Patients
A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients
A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients
A Dose-ranging Study for SPM 962 in Parkinson's Disease Patients
A Long-Term Extension Trial From Late Phase II of SPM 962 in Advanced Parkinson's Disease Patients
A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients
All 12 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 12